US Stock MarketDetailed Quotes

Dare Bioscience (DARE)

Watchlist
  • 2.170
  • -0.690-24.13%
Close May 15 16:00 ET
  • 2.190
  • +0.020+0.92%
Post 20:01 ET
32.51MMarket Cap-2.38P/E (TTM)

Dare Bioscience (DARE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.92%-5.52M
-280.61%-9.89M
-72.78%1.44M
92.54%-442.14K
-141.98%-5.42M
19.70%-5.47M
114.09%5.47M
164.87%5.31M
25.71%-5.92M
295.93%12.9M
Net income from continuing operations
31.48%-3M
-230.55%-13.4M
73.82%-1.44M
24.24%-3.56M
-131.11%-4.02M
35.19%-4.38M
86.56%-4.05M
-8.87%-5.51M
43.34%-4.7M
247.34%12.91M
Operating gains losses
88.32%-2.71K
-101.05%-6.3K
-102.88%-1.84K
----
----
-103.86%-23.18K
--600.2K
--63.93K
---63.73K
--0
Depreciation and amortization
215.78%554.64K
3,761.75%1.63M
8,291.88%534.4K
4,846.68%481.91K
2,766.77%442.54K
1,529.63%175.64K
10.33%42.33K
-36.19%6.37K
5.21%9.74K
60.55%15.44K
Other non cash items
6.86%143.13K
-150.82%-400.6K
-791.34%-1.11M
42.46%321.77K
25.62%250.1K
-34.12%133.95K
194.14%788.32K
114.38%160.04K
140.85%225.86K
116.79%199.09K
Change In working capital
-109.05%-3.67M
-86.61%789.26K
-69.26%3.1M
200.07%1.92M
-216.11%-2.48M
-17.11%-1.76M
156.52%5.89M
482.57%10.09M
-363.22%-1.92M
-154.99%-783.22K
-Change in receivables
-191.94%-114.7K
-147.70%-343.08K
-170.58%-203.9K
-147.23%-181.04K
-117.14%-82.88K
128.58%124.75K
-4.60%719.23K
60.02%288.9K
168.78%383.29K
-73.52%483.5K
-Change in prepaid assets
-156.19%-378.47K
-83.29%668.49K
-89.40%114.23K
123.10%84.51K
-110.26%-203.76K
-48.36%673.51K
761.03%4M
1.49%1.08M
-41.07%-365.86K
300.30%1.99M
-Change in payables and accrued expense
110.02%99.92K
-56.23%-1.93M
-189.04%-1.71M
108.75%49.31K
135.30%726.29K
-85.34%-997.71K
82.10%-1.24M
150.50%1.92M
38.87%-563.51K
-180.40%-2.06M
-Change in other current assets
-11,324.91%-1.63M
-416.33%-144.13K
-150.42%-47.32K
-101.63%-125.88K
108.12%14.54K
-92.48%14.54K
542.35%45.56K
-88.90%93.85K
88.50%-62.43K
-426.61%-179.1K
-Change in other current liabilities
-10.41%-145.11K
-19.33%-548.64K
-42.56%-143.41K
-14.58%-138.89K
-15.16%-134.91K
-8.80%-131.43K
-150.21%-459.76K
-108.31%-100.59K
-20.54%-121.22K
-19.86%-117.15K
-Change in other working capital
-4.26%-1.5M
9.39%3.09M
-25.21%5.09M
287.85%2.23M
-211.18%-2.8M
24.28%-1.44M
161.85%2.82M
419.72%6.81M
-160.32%-1.19M
53.39%-898.21K
Cash from discontinued investing activities
Operating cash flow
-0.92%-5.52M
-280.61%-9.89M
-72.78%1.44M
92.54%-442.14K
-141.98%-5.42M
19.70%-5.47M
114.09%5.47M
164.87%5.31M
25.71%-5.92M
295.93%12.9M
Investing cash flow
Cash flow from continuing investing activities
0
32.77%-385.28K
63.29%-206.64K
-161.88%-174.7K
153.78%153.4K
-2,056.40%-157.33K
8.96%-573.05K
7.32%-562.85K
1,377.55%282.33K
-285.23K
Net PPE purchase and sale
--0
32.77%-385.28K
63.29%-206.64K
-161.88%-174.7K
153.78%153.4K
-2,056.40%-157.33K
8.96%-573.05K
7.32%-562.85K
1,377.55%282.33K
---285.23K
Cash from discontinued investing activities
Investing cash flow
--0
32.77%-385.28K
63.29%-206.64K
-161.88%-174.7K
153.78%153.4K
-2,056.40%-157.33K
8.96%-573.05K
7.32%-562.85K
1,377.55%282.33K
---285.23K
Financing cash flow
Cash flow from continuing financing activities
-390.16%-715.47K
5,337.50%19.28M
300.70%424.13K
4,173.22%18.65M
-137.96%-43.79K
1,657.25%246.58K
-97.73%354.52K
-103.98%-211.32K
-94.91%436.44K
-74.49%115.37K
Net issuance payments of debt
-476.36%-1.08M
-7,481.41%-1.33M
-182.56%-529.01K
-121.47%-93.81K
-680.36%-521.26K
6.57%-187.22K
-106.57%-17.56K
6.57%-187.22K
-6.57%436.85K
---66.8K
Net common stock issuance
-78.25%94.89K
4,514.44%20.93M
2,197.48%1.27M
--18.74M
159.60%475.01K
102.80%436.25K
-95.15%453.58K
-92.94%55.49K
--0
-59.54%182.98K
Net preferred stock issuance
--297.21K
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
--0
--0
--0
Net other financing activities
-1,063.27%-28.5K
-294.72%-321.69K
----
----
----
-255.07%-2.45K
-101.73%-81.5K
---79.59K
---405
---815
Cash from discontinued financing activities
Financing cash flow
-390.16%-715.47K
5,337.50%19.28M
300.70%424.13K
4,173.22%18.65M
-137.96%-43.79K
1,657.25%246.58K
-97.73%354.52K
-103.98%-211.32K
-94.91%436.44K
-74.49%115.37K
Net cash flow
Beginning cash position
56.34%25.01M
47.98%16M
102.69%23.38M
-68.08%5.34M
168.05%10.63M
47.98%16M
-68.82%10.81M
-18.95%11.53M
22.33%16.71M
-80.00%3.97M
Current changes in cash
-15.88%-6.24M
71.38%9.01M
-63.33%1.66M
446.44%18.03M
-141.68%-5.31M
20.94%-5.38M
122.03%5.26M
230.34%4.53M
-996.92%-5.21M
307.61%12.73M
Effect of exchange rate changes
240.28%44.54K
110.58%7.19K
61.23%-25.66K
-70.09%6.86K
-11.47%12.89K
133.37%13.09K
-608.53%-67.91K
-212.94%-66.18K
252.60%22.93K
146.75%14.56K
End cash Position
77.04%18.82M
56.34%25.01M
56.34%25.01M
102.69%23.38M
-68.08%5.34M
168.05%10.63M
47.98%16M
47.98%16M
-18.95%11.53M
22.33%16.71M
Free cash flow
1.91%-5.52M
-309.59%-10.27M
-73.91%1.24M
89.07%-616.84K
-141.71%-5.26M
17.48%-5.63M
112.41%4.9M
153.98%4.74M
29.44%-5.64M
291.60%12.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.92%-5.52M-280.61%-9.89M-72.78%1.44M92.54%-442.14K-141.98%-5.42M19.70%-5.47M114.09%5.47M164.87%5.31M25.71%-5.92M295.93%12.9M
Net income from continuing operations 31.48%-3M-230.55%-13.4M73.82%-1.44M24.24%-3.56M-131.11%-4.02M35.19%-4.38M86.56%-4.05M-8.87%-5.51M43.34%-4.7M247.34%12.91M
Operating gains losses 88.32%-2.71K-101.05%-6.3K-102.88%-1.84K---------103.86%-23.18K--600.2K--63.93K---63.73K--0
Depreciation and amortization 215.78%554.64K3,761.75%1.63M8,291.88%534.4K4,846.68%481.91K2,766.77%442.54K1,529.63%175.64K10.33%42.33K-36.19%6.37K5.21%9.74K60.55%15.44K
Other non cash items 6.86%143.13K-150.82%-400.6K-791.34%-1.11M42.46%321.77K25.62%250.1K-34.12%133.95K194.14%788.32K114.38%160.04K140.85%225.86K116.79%199.09K
Change In working capital -109.05%-3.67M-86.61%789.26K-69.26%3.1M200.07%1.92M-216.11%-2.48M-17.11%-1.76M156.52%5.89M482.57%10.09M-363.22%-1.92M-154.99%-783.22K
-Change in receivables -191.94%-114.7K-147.70%-343.08K-170.58%-203.9K-147.23%-181.04K-117.14%-82.88K128.58%124.75K-4.60%719.23K60.02%288.9K168.78%383.29K-73.52%483.5K
-Change in prepaid assets -156.19%-378.47K-83.29%668.49K-89.40%114.23K123.10%84.51K-110.26%-203.76K-48.36%673.51K761.03%4M1.49%1.08M-41.07%-365.86K300.30%1.99M
-Change in payables and accrued expense 110.02%99.92K-56.23%-1.93M-189.04%-1.71M108.75%49.31K135.30%726.29K-85.34%-997.71K82.10%-1.24M150.50%1.92M38.87%-563.51K-180.40%-2.06M
-Change in other current assets -11,324.91%-1.63M-416.33%-144.13K-150.42%-47.32K-101.63%-125.88K108.12%14.54K-92.48%14.54K542.35%45.56K-88.90%93.85K88.50%-62.43K-426.61%-179.1K
-Change in other current liabilities -10.41%-145.11K-19.33%-548.64K-42.56%-143.41K-14.58%-138.89K-15.16%-134.91K-8.80%-131.43K-150.21%-459.76K-108.31%-100.59K-20.54%-121.22K-19.86%-117.15K
-Change in other working capital -4.26%-1.5M9.39%3.09M-25.21%5.09M287.85%2.23M-211.18%-2.8M24.28%-1.44M161.85%2.82M419.72%6.81M-160.32%-1.19M53.39%-898.21K
Cash from discontinued investing activities
Operating cash flow -0.92%-5.52M-280.61%-9.89M-72.78%1.44M92.54%-442.14K-141.98%-5.42M19.70%-5.47M114.09%5.47M164.87%5.31M25.71%-5.92M295.93%12.9M
Investing cash flow
Cash flow from continuing investing activities 032.77%-385.28K63.29%-206.64K-161.88%-174.7K153.78%153.4K-2,056.40%-157.33K8.96%-573.05K7.32%-562.85K1,377.55%282.33K-285.23K
Net PPE purchase and sale --032.77%-385.28K63.29%-206.64K-161.88%-174.7K153.78%153.4K-2,056.40%-157.33K8.96%-573.05K7.32%-562.85K1,377.55%282.33K---285.23K
Cash from discontinued investing activities
Investing cash flow --032.77%-385.28K63.29%-206.64K-161.88%-174.7K153.78%153.4K-2,056.40%-157.33K8.96%-573.05K7.32%-562.85K1,377.55%282.33K---285.23K
Financing cash flow
Cash flow from continuing financing activities -390.16%-715.47K5,337.50%19.28M300.70%424.13K4,173.22%18.65M-137.96%-43.79K1,657.25%246.58K-97.73%354.52K-103.98%-211.32K-94.91%436.44K-74.49%115.37K
Net issuance payments of debt -476.36%-1.08M-7,481.41%-1.33M-182.56%-529.01K-121.47%-93.81K-680.36%-521.26K6.57%-187.22K-106.57%-17.56K6.57%-187.22K-6.57%436.85K---66.8K
Net common stock issuance -78.25%94.89K4,514.44%20.93M2,197.48%1.27M--18.74M159.60%475.01K102.80%436.25K-95.15%453.58K-92.94%55.49K--0-59.54%182.98K
Net preferred stock issuance --297.21K------------------0----------------
Proceeds from stock option exercised by employees --------------------------0--0--0--0
Net other financing activities -1,063.27%-28.5K-294.72%-321.69K-------------255.07%-2.45K-101.73%-81.5K---79.59K---405---815
Cash from discontinued financing activities
Financing cash flow -390.16%-715.47K5,337.50%19.28M300.70%424.13K4,173.22%18.65M-137.96%-43.79K1,657.25%246.58K-97.73%354.52K-103.98%-211.32K-94.91%436.44K-74.49%115.37K
Net cash flow
Beginning cash position 56.34%25.01M47.98%16M102.69%23.38M-68.08%5.34M168.05%10.63M47.98%16M-68.82%10.81M-18.95%11.53M22.33%16.71M-80.00%3.97M
Current changes in cash -15.88%-6.24M71.38%9.01M-63.33%1.66M446.44%18.03M-141.68%-5.31M20.94%-5.38M122.03%5.26M230.34%4.53M-996.92%-5.21M307.61%12.73M
Effect of exchange rate changes 240.28%44.54K110.58%7.19K61.23%-25.66K-70.09%6.86K-11.47%12.89K133.37%13.09K-608.53%-67.91K-212.94%-66.18K252.60%22.93K146.75%14.56K
End cash Position 77.04%18.82M56.34%25.01M56.34%25.01M102.69%23.38M-68.08%5.34M168.05%10.63M47.98%16M47.98%16M-18.95%11.53M22.33%16.71M
Free cash flow 1.91%-5.52M-309.59%-10.27M-73.91%1.24M89.07%-616.84K-141.71%-5.26M17.48%-5.63M112.41%4.9M153.98%4.74M29.44%-5.64M291.60%12.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More